Clopidogrel Tablet
Product Images NDC 67296-2266

This text contains information about Clopidogrel tablets, USP 75 mg, with the NDC code 16714-052-04. Each tablet contains 97.875 mg of clopidogrel bisulfate, USP equivalent to 75 mg of clopidogrel base. The recommended adult dosage and storage conditions are provided. The medication guide is available online or through a contact number. The product is manufactured by Macleods Pharmaceuticals Ltd. in India.*

Each tablet contains 97.875 mg of clopidogrel bisulfate, equivalent to 75 mg of clopidogrel base. This medication is commonly used for its antiplatelet properties. The usual adult dosage can be found in the package insert. Store the tablets at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Pharmacists are advised to dispense this medication and provide the Medication Guide to each patient. For more information, visit the manufacturer's website or call the provided number. The tablets are manufactured by NorthStar RX LLC and the product is of Indian origin.*

Each tablet contains 97.875 mg of clopidogrel bisufate, USP, which is equivalent to 75 mg of clopidogrel base. The usual adult dosage can be found in the package insert. Store the tablets at 20° to 25°C (68° to 77° F); excursions permitted to 15° to 30° C (59° to 86° F). Dispense Medication Guide available on www.northstamxiic.com/products or call 1-800-206-7821. Manufactured for Northstar Pharmaceuticals by Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, INDIA. Contains 500 tablets.*

Each tablet contains 97.875 mg of clopidogrel bisulfate, USP, equivalent to 75 mg of clopidogrel base. This medication is typically used for adults with dosages specified in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C. It is essential to consult the pharmacist and follow the Medication Guide provided. This product is available in a package of 90 tablets and manufactured by Northstarrxlic. For more information, visit their website or call their customer service.*

This text provides information regarding the effect of co-administered PPIs (proton pump inhibitors) on the active metabolite AUC (area under the curve). It compares the mean and 90% confidence interval for different PPIs (Dexlansoprazole, 60 mg; Lansoprazole, 30 mg; Pantoprazole, 80 mg; Omeprazole, 80 mg) in relation to Clopidogrel administered alone. The data is presented graphically showing changes relative to Clopidogrel alone.*

This text presents a comparison between the use of Placebo with aspirin and Clopidogrel with aspirin over 12 months of follow-up. The numeric value 0.00009 indicates a certain outcome or result of the comparison. Other standard therapies were also utilized as needed during the study.*

This text provides data on the effects of Clopidogrel compared to a placebo in reducing deaths. It shows that Clopidogrel resulted in a 7% proportional risk reduction in comparison to the placebo, with statistical significance (p=0.03). Additionally, all treated patients in the study received aspirin during the evaluation period.*

This text appears to mention medical terms related to patient care and treatment. It talks about the use of aspirin in treated patients and possible issues such as infarction. The text may be referencing a study or report related to cardiovascular health.*

This -generated text provides information about a medication with the National Drug Code (NDC) 16714-052-01. The medication is in tablet form and contains 97.875 mg of clopidogrel bisulfate, which is equivalent to 75 mg of clopidogrel base. The usual adult dosage is not mentioned, and it advises referring to the package insert for further details. The storage conditions are indicated as 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C. The medication is manufactured by Macleods Pharmaceuticals Ltd. in India and dispensed by NorthStarRx LLC. The text also mentions a Medication Guide available online or via phone call. Furthermore, the product comes in packs of 30 tablets and includes contact information for Northstar Healthcare Holdings Ltd. and a code number.*

This is a description of Clopidogrel tablets, USP 75 mg. Each tablet contains 97.875 mg of clopidogrel bisulfate, USP, equivalent to 75 mg of clopidogrel base. The usual adult dosage is indicated in the package insert. The tablets are to be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The pharmacist is instructed to dispense the Medication Guide provided separately to each patient. The medication guide can also be accessed online or by calling a specific number. The tablets are manufactured in India.*

Each tablet contains 97.875 mg of clopidogrel bisulfate, USP, which is equivalent to 75 mg of clopidogrel base. The usual adult dosage is 75 mg. Store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). This medication is dispensed individually to each patient. Manufactured by NorthStar Rx LLC for Macleods Pharmaceuticals Ltd. This product is a controlled room temperature drug. For more information, visit the website or call the provided number. Contains 90 tablets.*

This text contains information about Clopidogrel Tablets, USP 75 mg. The medication guide should be dispensed to each patient. The tablets are manufactured by Macleods Pharmaceuticals Ltd in India and distributed by NorthStar Rx LLC in the USA. The tablets contain 97.875 mg of clopidogrel bisulfate, USP equivalent to 75 mg of clopidogrel base. The usual adult dosage and storage instructions are provided. For more information, one can visit the website www.northstamic.com/products or call 1-800-206-7821.*